Effects of rotigotine on sleep in Parkinson’s disease patients: a Parkinson’s KinetiGraph study

Effects of rotigotine on sleep in Parkinson’s disease patients: a Parkinson’s KinetiGraph study

IntroductionRecent studies suggest that the dopamine agonist (DA) rotigotine improves sleep among Parkinson disease (PD) patients. Parkinson’s KinetiGraph (PKG) offers a home-based alternative for evaluating sleep. We investigated the effect of rotigotine on sleep in PD patients with PKG and questio...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sotirios Grigoriou, Carin Janz, Malcolm Horne, Filip Bergquist, Nil Dizdar, Per Odin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Neurology
Subjects:	Parkinson’s disease Parkinson’s KinetiGraph rotigotine sleep disturbances Parkinson disease sleep scale-2 sleep quality
Online Access:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1591537/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Perioperative Treatment with High Dose Rotigotine and Amantadine Combination in a Patient with Advanced Stage Parkinson’s Disease After Esophagectomy
by: Yankov G., et al.
Published: (2025-04-01)

Sedation and sleep safety of pimavanserin for Parkinsons’s disease psychosis: Review and exploratory analysis of clinical study data
by: Ana Berrio, et al.
Published: (2025-01-01)

Acupuncture versus sham acupuncture in the treatment of insomnia for patients with Parkinson’s disease: a randomized controlled clinical trial
by: Shuting Liu, et al.
Published: (2025-07-01)

Efficacy of Yijinjing-inspired exercises on sleep disorders in Parkinson’s disease: a controlled fNIRS study
by: Zekai Hu, et al.
Published: (2025-07-01)

Brain structural MRI marker for predicting conversion to Parkinson’s disease in individuals with prodromal symptoms
by: Chang-hyun Park, et al.
Published: (2025-07-01)

Chronic sleep deprivation induces plasma exosome-derived miR-150-5p downregulation as a novel mechanism involved in Parkinson’s disease progression by targeting DCLK1
by: Li Liu, et al.
Published: (2025-07-01)

Unusual presentation of neurobrucellosis presenting with the features of parkinsonism: two case reports and a review of the literature
by: Moneera Aldraihem, et al.
Published: (2025-08-01)

Use of Acupuncture in the Rehabilitation Treatment of Patients with Parkinson's Disease
by: Julio López Argüelles, et al.
Published: (2023-04-01)

Determining the usability of computer input devices by Parkinson's disease sufferers
by: L. de Wet, et al.
Published: (2005-02-01)

Exploring the public’s perception and understanding of Parkinson’s disease in Ireland: a study protocol
by: Sophie Crooks, et al.
Published: (2025-07-01)

Síndrome de Horner após cirurgia estereotáxica para doença de Parkinson Horner syndrome after stereotactic Parkinson's surgery
by: Luiz A. Rogano, et al.
Published: (2003-06-01)

Discinesias induzidas por levodopa em 176 pacientes com doença de Parkinson Levodopa-induced dyskinesias in 176 parkisonian patients
by: Maria Sheila G. Rocha, et al.
Published: (1995-12-01)

Parkinson's Disease - diagnosis and current management options
by: J.A. Smuts
Published: (2003-06-01)

Compound impact of cognitive and physical decline: A qualitative interview study of people with Parkinson's and cognitive impairment, caregivers and professionals
by: Jennifer S. Pigott, et al.
Published: (2024-02-01)

Parkinsonism amongst white missionary workers in Malawi: 1889- 1989
by: F.P. Retief, et al.
Published: (2003-10-01)

Fluency in Parkinson?s disease: disease duration, cognitive status and age
by: Natalia Casagrande Brabo, et al.
Published: (2014-05-01)

Modeling long-term health and economic implications of new treatment strategies for Parkinson’s disease: an individual patient simulation study
by: Conor Chandler, et al.
Published: (2021-01-01)

Can the CERAD neuropsychological battery be used to assess cognitive impairment in Parkinson's disease?
by: Carlos Henrique Ferreira Camargo, et al.

Case Report: Decoding genetic risks of vascular parkinsonism: a case series
by: Ali Shalash, et al.
Published: (2025-07-01)

Executive dysfunction and motor symptoms in Parkinson's disease Disfunções executivas e sintomas motores na doença de Parkinson
by: Indira Silveira Campos-Sousa, et al.
Published: (2010-04-01)

Electrophysiologic characteristics of tremor in Parkinson?s disease and essential tremor
by: Ederson Cichaczewski, et al.
Published: (2014-04-01)

«Faciem morbo»: personal characteristics of patients with Parkinson’s disease
by: V. A. Bogacheva, et al.
Published: (2020-10-01)

When do the symptoms of autonomic nervous system malfunction appear in patients with Parkinson’s disease?
by: De Luka Silvio R., et al.
Published: (2014-01-01)

Are static posturography-assisted biofeedback exercises effective in Parkinson's disease?
by: Elif Yakşi, et al.
Published: (2022-09-01)

The Role of Vitamin D in Parkinson's Disease
by: Fatma Öznur Afacan, et al.
Published: (2025-05-01)

Metabolic syndrome and dementia associated with Parkinson's disease: impact of age and hypertension
by: Arthur Oscar Schelp, et al.
Published: (2012-02-01)

USE OF THREE-COMPONENT LEVODOPA (LEVODOPA/CARBIDOPA/ENTACAPONE) TO CORRECT NOCTURNAL SYMPTOMS OF PARKINSON,S DISEASE
by: T. K. Kulua, et al.
Published: (2015-08-01)

Psychometric properties of the Italian version of scale for outcomes in Parkinson’s disease psychiatric complications in Parkinson disease
by: Sofia Cuoco, et al.
Published: (2025-05-01)

Evaluation of Spatio-Temporal Gait Variability during Obstacle Crossing in Parkinson\'s Disease
by: Elaheh Azadian, et al.
Published: (2023-12-01)

Wearable Surface Electromyography System to Predict Freeze of Gait in Parkinson’s Disease Patients
by: Anna Moore, et al.
Published: (2024-12-01)

Low serum uric acid levels and levodopa-induced dyskinesia in Parkinson's disease
by: Nayron Medeiros Soares, et al.
Published: (2023-01-01)

Alpha-synuclein inclusions reduced by PIKfyve inhibition in Parkinson disease cell models
by: Sara Lucas-Del-Pozo, et al.
Published: (2025-10-01)

Neurodegeneration in Parkinson’s disease: are we looking at the right spot?
by: Gabriel S. Rocha, et al.
Published: (2025-08-01)

Nocturnal polyuria is common in Parkinson’s and is associated with orthostatic hypotension
by: Matthew D Smith, et al.
Published: (2025-01-01)

Ultrasonido transcraneal en el diagnóstico del Parkinson
by: Aniley Martínez González, et al.
Published: (2014-10-01)

The role of T cells in the treatment of Parkinson’s disease
by: Zhuomiao Lin, et al.
Published: (2025-08-01)

Objective and subjective analysis of women's voice with idiopathic Parkinson's disease
by: Riviana Rodrigues das Graças, et al.
Published: (2012-07-01)

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease
by: Bruno Lopes SANTOS-LOBATO, et al.
Published: (2020-04-01)

Telehealth For Individuals with Parkinson’s Disease During Covid-19 In Brazil: A Prospective Case Series
by: Natália Mariano Barboza, et al.
Published: (2022-12-01)

Parkinson’s Disease Detection Based on Transfer Learning
by: Mohammad Talal Ghazal
Published: (2024-09-01)